Haemonetics Corporation (HAE) Q3 2014 Earnings Results

Haemonetics Corp Beats on EPS, Stock Down 3.62%

Haemonetics Corp's earnings report showed a positive surprise in EPS, but the stock fell by 3.62% following the announcement. Investors may be reacting to the lack of revenue data and the absence of updated guidance, which could indicate uncertainty about future performance. The cautious tone from management may also have contributed to the stock's decline.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.61	N/A	+0.33%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a cautious outlook, emphasizing the need for operational improvements. They remain focused on long-term growth strategies.

Management highlighted ongoing challenges in the market.

They expressed commitment to improving operational efficiencies.

There was a focus on long-term growth despite short-term hurdles.

Haemonetics Corp Beats on EPS, Stock Down 3.62%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corp Beats on EPS, Stock Down 3.62%

Key numbers

Management commentary